Pierluigi Ballabeni
Correction to: Ruptured PICA aneurysms: presentation and treatment outcomes compared to other posterior circulation aneurysms. A Swiss SOS study
Starnoni D, Marbacher S, D'Alonzo D, Remonda L, Machi P, Gralla J, Bijlenga P, Saliou G, Ballabeni P, Levivier M, Swiss SOS group, Messerer M, Blackham K, Roethlisberger M, Maduri R, Al Taha K, Bervini D, Zumofen D, Stienen M, Schatlo B, Fung C, Robert T, Seule M, Burkhardt J, Maldaner N, Daniel R. Correction to: Ruptured PICA aneurysms: presentation and treatment outcomes compared to other posterior circulation aneurysms. A Swiss SOS study. Acta Neurochir (Wien) 2019; 161:1335-1336.
01.07.2019Correction to: Ruptured PICA aneurysms: presentation and treatment outcomes compared to other posterior circulation aneurysms. A Swiss SOS study
01.07.2019Acta Neurochir (Wien) 2019; 161:1335-1336
Starnoni Daniele, Marbacher Serge, D'Alonzo Donato, Remonda Luca, Machi Paolo, Gralla Jan, Bijlenga Philippe, Saliou Guillaume, Ballabeni Pierluigi, Levivier Marc, Swiss SOS group, Messerer Mahmoud, Blackham Kristine A, Roethlisberger Michel, Maduri Rodolfo, Al Taha Khalid, Bervini David, Zumofen Daniel Walter, Stienen Martin N., Schatlo Bawarjan, Fung Christian, Robert Thomas, Seule Martin A, Burkhardt Jan-Karl, Maldaner Nicolai, Daniel Roy Thomas
Ruptured PICA aneurysms: presentation and treatment outcomes compared to other posterior circulation aneurysms. A Swiss SOS study
Starnoni D, Marbacher S, D'Alonzo D, Remonda L, Machi P, Gralla J, Bijlenga P, Saliou G, Ballabeni P, Levivier M, Messerer M, Swiss SOS group, Blackham K, Röthlisberger M, Maduri R, Al Taha K, Bervini D, Zumofen D, Stienen M, Schatlo B, Fung C, Robert T, Seule M, Burkhardt J, Maldaner N, Daniel R. Ruptured PICA aneurysms: presentation and treatment outcomes compared to other posterior circulation aneurysms. A Swiss SOS study. Acta Neurochir (Wien) 2019; 161:1325-1334.
26.04.2019Ruptured PICA aneurysms: presentation and treatment outcomes compared to other posterior circulation aneurysms. A Swiss SOS study
26.04.2019Acta Neurochir (Wien) 2019; 161:1325-1334
Starnoni Daniele, Marbacher Serge, D'Alonzo Donato, Remonda Luca, Machi Paolo, Gralla Jan, Bijlenga Philippe, Saliou Guillaume, Ballabeni Pierluigi, Levivier Marc, Messerer Mahmoud, Swiss SOS group, Blackham Kristine A, Röthlisberger Michel, Maduri Rodolfo, Al Taha Khalid, Bervini David, Zumofen Daniel Walter, Stienen Martin Nikolaus, Schatlo Bawarjan, Fung Christian, Robert Thomas, Seule Martin, Burkhardt Jan-Karl, Maldaner Nicolai, Daniel Roy Thomas
Correction to: Ruptured posterior circulation aneurysms: epidemiology, patterns of care, and outcomes from the Swiss SOS national registry
Maduri R, Marbacher S, D'Alonzo D, Remonda L, Machi P, Gralla J, Bijlenga P, Saliou G, Ballabeni P, Levivier M, Messerer M, Daniel R, Blackham K, Röthlisberger M, Starnoni D, Rocca A, Bervini D, Zumofen D, Stienen M, Schatlo B, Fung C, Robert T, Seule M, Burkhardt J, Maldaner N, Swiss SOS group. Correction to: Ruptured posterior circulation aneurysms: epidemiology, patterns of care, and outcomes from the Swiss SOS national registry. Acta Neurochir (Wien) 2019; 161:781.
01.04.2019Correction to: Ruptured posterior circulation aneurysms: epidemiology, patterns of care, and outcomes from the Swiss SOS national registry
01.04.2019Acta Neurochir (Wien) 2019; 161:781
Maduri Rodolfo, Marbacher Serge, D'Alonzo Donato, Remonda Luca, Machi Paolo, Gralla Jan, Bijlenga Philippe, Saliou Guillaume, Ballabeni Pierluigi, Levivier Marc, Messerer Mahmoud, Daniel Roy Thomas, Blackham Kristine A, Röthlisberger Michel, Starnoni Daniele, Rocca Alda, Bervini David, Zumofen Daniel Walter, Stienen Martin N., Schatlo Bawarjan, Fung Christian, Robert Thomas, Seule Martin A, Burkhardt Jan-Karl, Maldaner Nicolai, Swiss SOS group
Ruptured posterior circulation aneurysms: epidemiology, patterns of care, and outcomes from the Swiss SOS national registry
Maduri R, Marbacher S, D'Alonzo D, Remonda L, Machi P, Gralla J, Bijlenga P, Saliou G, Ballabeni P, Levivier M, Messerer M, Daniel R, Blackham K, Röthlisberger M, Starnoni D, Rocca A, Bervini D, Zumofen D, Stienen M, Schatlo B, Fung C, Robert T, Seule M, Burkhardt J, Maldaner N, Swiss SOS group. Ruptured posterior circulation aneurysms: epidemiology, patterns of care, and outcomes from the Swiss SOS national registry. Acta Neurochir (Wien) 2019; 161:769-779.
25.01.2019Ruptured posterior circulation aneurysms: epidemiology, patterns of care, and outcomes from the Swiss SOS national registry
25.01.2019Acta Neurochir (Wien) 2019; 161:769-779
Maduri Rodolfo, Marbacher Serge, D'Alonzo Donato, Remonda Luca, Machi Paolo, Gralla Jan, Bijlenga Philippe, Saliou Guillaume, Ballabeni Pierluigi, Levivier Marc, Messerer Mahmoud, Daniel Roy Thomas, Blackham Kristine A, Röthlisberger Michel, Starnoni Daniele, Rocca Alda, Bervini David, Zumofen Daniel Walter, Stienen Martin Nikolaus, Schatlo Bawarjan, Fung Christian, Robert Thomas, Seule Martin, Burkhardt Jan-Karl, Maldaner Nicolai, Swiss SOS group
The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas
Laurencet F, Zulian G, Plancherel C, Luthi J, Fey M, Cerny T, Hess U, Rufener B, Ballabeni P, Swiss Group for Clinical Research (SAKK). The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas. Acta haematologica 2007; 117:40-7.
01.01.2007The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas
01.01.2007Acta haematologica 2007; 117:40-7
Laurencet France, Zulian Gilbert B, Plancherel Catherine, Luthi Jean-Marc, Fey Martin, Cerny Thomas, Hess Urs, Rufener Beatrice, Ballabeni Pierluigi, Swiss Group for Clinical Research (SAKK)
Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial
Thürlimann B, Rochlitz C, Aebi S, Perey L, Pagani O, Ballabeni P, Senn I, Köberle D, Hess D, Goldhirsch A. Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial. Breast Cancer Res Treat 2004; 85:247-54.
01.06.2004Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial
01.06.2004Breast Cancer Res Treat 2004; 85:247-54
Thürlimann Beat, Rochlitz Christoph, Aebi Stefan, Perey Lucien, Pagani Olivia, Ballabeni Pierluigi, Senn Isabella, Köberle Dieter, Hess Dagmar, Goldhirsch Aron